The Center for Healthcare Quality Assessment and Control of the Ministry of Health of the Russian Federation conducted a systematic review “Current Research Data on Drug Therapy for Novel Coronavirus Associated Disease (COVID-19).
The objective of the review was to analyze research studies of drugs used for the COVID-19 prevention and treatment and to identify ongoing randomized controlled trials (RCT) of such drugs.
The review was published in Russian in the journal “Medical Technologies. Assessment and Choice”.
The article is available here